Pricey Pradaxa aces cost-effectiveness study

When is an $8-a-day drug a bargain compared with one that costs just a dollar? When the expensive drug is Boehringer Ingelheim's new blood thinner Pradaxa, according to a study by Stanford researchers. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.